Last reviewed · How we verify
NCT07378150
Clay Therapy in Schizophrenia Patients
NA trial testing Clay therapy in Schizophrenia and Related Disorders in 17 participants. Currently enrolling.
9 January 2026
Quick facts
| Lead sponsor | Kutahya Health Sciences University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 17 |
| Start date | 1 December 2025 |
| Primary completion | 9 January 2026 |
| Estimated completion | 20 February 2026 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Clay therapy
Conditions studied
- Schizophrenia and Related Disorders — all drugs for Schizophrenia and Related Disorders →
Sponsor
Kutahya Health Sciences University
Who can join
18 and older, any sex, with Schizophrenia and Related Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In recent years, art therapies have been discussed for their positive effects on mental disorders. One such therapy, clay therapy, is being studied to examine its effect on the functional recovery and individual and social performance of schizophrenia patients undergoing pharmacological treatment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07378150
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Schizophrenia and Related Disorders
Currently open trials in the same condition.
- NCT07119268 — SPARK Healthy Sleep · NA · recruiting
- NCT05603104 — Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First- · Phase 3 · recruiting
- NCT02916810 — Alternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation Treatment · NA · recruiting
- NCT06426134 — Ketosis Impact on Signs & Symptoms of Schizophrenia and Bipolar disorderS · NA · recruiting
- NCT05958875 — The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subje · Phase 4 · recruiting
Other Kutahya Health Sciences University trials
Trials by the same sponsor.
- NCT07522658 — Artificial Intelligence-Generated vs Academician-Developed Multiple True/False Questions in Anesthesiology Education · not yet recruiting
- NCT07536685 — THE TURKISH VERSION OF THE EKSTEROCEPTIVE BODY AWARENESS QUESTIONNAIRE · enrolling by invitation
- NCT07501416 — High-Intensity Laser Therapy in Hemiplegic Shoulder Pain · NA · not yet recruiting
- NCT07504887 — Effects of Aerobic Exercise in Rheumatoid Arthritis · NA · not yet recruiting
- NCT07460193 — CBCT and Audiological Analysis of the TMJ-Tinnitus Relationship · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07378150 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kutahya Health Sciences University
- Last refreshed: 30 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07378150.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing